Press Resease

Oncology Nutrition Market by Cancer Type (Blood, Liver, Pancreatic, Breast, Lung, Head & Neck, Esophageal, Stomach & Gastrointestinal): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Published Date: 20-Jul-2018 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3241 Status : Published

Global oncology nutrition market expected to generate revenue of around USD 2368.70 million by end of 2024, growing at a CAGR of around 8.85% between 2018 and 2024. Oncology nutrition is a vital part of the entire process of recovering from cancer. Consuming a wide variety of foods and nutritious meals helps in coping with the heavy medication that is a part of cancer treatment.

Description

The report covers forecast and analysis for the oncology nutrition market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the oncology nutrition market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the oncology nutrition market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the oncology nutrition market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein cancer type segment is benchmarked based on their market size, growth rate, and general attractiveness.

Global Oncology Nutrition Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis. 

The study provides a decisive view on the oncology nutrition market by segmenting the market based on cancer type and regions. Both the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on cancer type, the oncology nutrition market has been segmented into blood, liver, pancreatic, breast, lung, head & neck, esophageal, and stomach & gastrointestinal. Head & neck cancer segment holds the maximum share of the global oncology nutrition market.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further divided into major countries including the U.S. Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for oncology nutrition based on individual segment and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Fresenius Kabi AG, Nestle S.A., Abbott Laboratories, Danone, Global Health Products, Mead Johnson Nutrition Company, B.Braun Melsungen AG, Victus, Meiji Holdings, and Hormel Foods.

This report segments the global oncology nutrition market as follows:

Global Oncology Nutrition Market: By Cancer Type

  • Blood
  • Liver
  • Pancreatic
  • Breast
  • Lung
  • Head & Neck
  • Esophageal
  • Stomach & Gastrointestinal

Global Oncology Nutrition Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Oncology Nutrition market, 2017 - 2024 (USD Million)
    • 2.2. Global Oncology Nutrition market : Snapshot
  •  
  • Chapter 3. Oncology Nutrition- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global oncology nutrition market drivers: Impact analysis
      • 3.2.2. Increasing demand for nutritional feeding in homecare sector
      • 3.2.3. Growing trend towards enteral mode of nutrition from parenteral
    • 3.3. Market Restraints
      • 3.3.1. Global oncology nutrition market restraints: Impact analysis
      • 3.3.2. Tube feeding-related complications
    • 3.4. Opportunities
      • 3.4.1. Rapid product innovation
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by cancer type segment
  •  
  • Chapter 4. Global Oncology Nutrition Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global oncology nutrition market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  •  
  • Chapter 5. Global Oncology Nutrition Market - Cancer Type Segment Analysis
    • 5.1. Global oncology nutrition market: Cancer Type overview
      • 5.1.1. Global oncology nutrition market revenue share, by Cancer Type, 2017 and 2024
    • 5.2. Blood
      • 5.2.1. Global oncology nutrition market for Blood, 2017 - 2024 (USD Million)
    • 5.3. Liver
      • 5.3.1. Global oncology nutrition market for Liver, 2017 - 2024 (USD Million)
    • 5.4. Pancreatic
      • 5.4.1. Global oncology nutrition market for Pancreatic, 2017 - 2024 (USD Million)
    • 5.5. Breast
      • 5.5.1. Global oncology nutrition market for Breast, 2017 - 2024 (USD Million)
    • 5.6. Lung
      • 5.6.1. Global oncology nutrition market for Lung, 2017 - 2024 (USD Million)
    • 5.7. Head & Neck
      • 5.7.1. Global oncology nutrition market for Head & Neck, 2017 - 2024 (USD Million)
    • 5.8. Esophageal
      • 5.8.1. Global oncology nutrition market for Esophageal, 2017 - 2024 (USD Million)
    • 5.9. Stomach & Gastrointestinal
      • 5.9.1. Global oncology nutrition market for Stomach & Gastrointestinal, 2017 - 2024 (USD Million)
  •  
  • Chapter 6. Global Oncology Nutrition Market - Regional Segment Analysis
    • 6.1. Global oncology nutrition market: Regional overview
      • 6.1.1. Global oncology nutrition market revenue share, by region, 2017 and 2024
    • 6.2. North America
      • 6.2.1. North America oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.2.2. U.S.
        • 6.2.2.1. U.S. oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.2.3. Canada
        • 6.2.3.1. Canada oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.2.4. Rest of North America
        • 6.2.4.1. Rest of North America oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.3.2. Germany
        • 6.3.2.1. Germany oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.3.3. U.K.
        • 6.3.3.1. U.K. oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.3.4. France
        • 6.3.4.1. France oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.3.5. Italy
        • 6.3.5.1. Italy oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.3.6. Spain
        • 6.3.6.1. Spain oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.3.7. Russia
        • 6.3.7.1. Russia oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.3.8. Rest of Europe
        • 6.3.8.1. Rest of Europe oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.4.2. China
        • 6.4.2.1. China oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.4.3. Japan
        • 6.4.3.1. Japan oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.4.4. India
        • 6.4.4.1. India oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.4.5. Australia
        • 6.4.5.1. Australia oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.4.6. Rest of Asia Pacific
        • 6.4.6.1. Rest of Asia Pacific oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.5.2. Brazil
        • 6.5.2.1. Brazil oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.5.3. Mexico
        • 6.5.3.1. Mexico oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.5.4. Argentina
        • 6.5.4.1. Argentina oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.5.5. Rest of Latin America
        • 6.5.5.1. Rest of Latin America oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
    • 6.6. Middle East and Africa
      • 6.6.1. Middle East and Africa oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.6.2. Saudi Arabia
        • 6.6.2.1. Saudi Arabia oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.6.3. UAE
        • 6.6.3.1. UAE oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.6.4. South Africa
        • 6.6.4.1. South Africa oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.6.5. Qatar
        • 6.6.5.1. Qatar oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
      • 6.6.6. Rest of Middle East and Africa
        • 6.6.6.1. Rest of Middle East and Africa oncology nutrition market revenue, by cancer type, 2017 - 2024 (USD Million)
  •  
  • Chapter 7. Company Profile
    • 7.1. Fresenius Kabi AG
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Therapy portfolio
      • 7.1.4. Business strategy
      • 7.1.5. Recent developments
    • 7.2. Nestle S.A.
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Therapy portfolio
      • 7.2.4. Business strategy
      • 7.2.5. Recent developments
    • 7.3. Abbott Laboratories
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Therapy portfolio
      • 7.3.4. Business strategy
      • 7.3.5. Recent developments
    • 7.4. Danone
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Therapy portfolio
      • 7.4.4. Business strategy
      • 7.4.5. Recent developments
    • 7.5. Global Health Products
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Therapy portfolio
      • 7.5.4. Business strategy
      • 7.5.5. Recent developments
    • 7.6. Mead Johnson Nutrition Company
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Therapy portfolio
      • 7.6.4. Business strategy
      • 7.6.5. Recent developments
    • 7.7. B.Braun Melsungen AG
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Therapy portfolio
      • 7.7.4. Business strategy
      • 7.7.5. Recent developments
    • 7.8. Victus
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Therapy portfolio
      • 7.8.4. Business strategy
      • 7.8.5. Recent developments
    • 7.9. Meiji Holdings
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Therapy portfolio
      • 7.9.4. Business strategy
      • 7.9.5. Recent developments
    • 7.10. Hormel Foods
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Therapy portfolio
      • 7.10.4. Business strategy
      • 7.10.5. Recent developments

Methodology

Free Analysis

Good nutrition is one of the most important things required to lead a healthy life and in patients suffering from cancer a balanced nutrition is even more important. Oncology nutrition is a vital part of the entire process for recovering from cancer. Consuming a wide variety of foods and nutritious meals helps in coping with the heavy medication that is a part of cancer treatment. Following a well-balanced oncology, nutrition helps in improving strength, maintaining body weight, and assists the body in recovering from cancer. In most cases, well-nourished patients respond better to cancer treatments. Balanced oncology nutrition includes consumption of foods and liquids that are rich in macronutrients - which include proteins, fats, and carbohydrates as well as micronutrients such as minerals and vitamins. A qualified and registered dietician is an important member of the healthcare team taking care of the cancer patients. The dietician provides focused counseling about proper oncology nutrition to be followed during the cancer treatment.

Following well-balanced oncology nutrition is vital to prevent malnutrition during the course of cancer treatment. It also helps the patients to achieve and maintain a healthy weight, to manage the side-effects of cancer treatment, to be physically active, and at the same time reduces the risk of cancer coming back. It is observed that people diagnosed with cancer are highly motivated to improve or maintain their health. The patients often search for information on the web or reach out to experts. The major aim during the cancer treatment is to eat healthy and keep the body replete with nutrients and calories for healing, recovery, repair, and energy. A well-balanced diet must be coupled with targeted oncology nutrition products during and after cancer treatment. The products packed with macro- and micro-nutrients fill the nutrition gap left by regular meals. In cancer patients, inadequate intake of calories, proteins, or other nutrients like vitamins and minerals can lead to malnourishment.

Global Oncology Nutrition Market

Malnourishment, caused due to cancer treatment or other related complications, can make patients weak or drained. Furthermore, it may lead to disruptions or delays in the cancer treatment and longer hospital stays. On the other hand, consuming excessive calories could lead to excessive weight gain, in turn, increasing the risk of cancer recurrence. According to Cancer Treatment Centers of America (CTCA), approximately 65 to 70% of oncology patients suffer from malnutrition. In 2015 WHO recorded cancer as the second leading cause of death globally and which accounted for 8.8 million deaths. WHO further stated that between 30% and 50% of cancer deaths are preventable by avoiding key risk factors that include tobacco products, alcohol consumption, and by maintaining a healthy body weight.

Increasing demand for nutritional feeding in homecare sector, growing trend towards an enteral mode of nutrition from parenteral, increasing number of cancer cases, and increasing incidence of malnutrition in cancer patients are expected to be the major drivers for the global oncology nutrition market. In addition, developing clinical research in oncology nutrition is expected to trigger the growth of global oncology nutrition industry in the coming years. However, tube feeding-related complications and restricted reimbursement may pose challenges to oncology nutrition market. Rapid product innovation and advancement of elemental formulas in the field is expected to act as an opportunity for oncology nutrition market in the near future.

Based on cancer type, the oncology nutrition market has been segmented into blood, liver, pancreatic, breast, lung, head & neck, esophageal, and stomach & gastrointestinal. Head & neck segment holds the maximum share of global oncology nutrition market.

North America will be the dominant region during the forecast period. Increasing prevalence of cancer in the region and availability of assisted living facilities are the factors that will boost the market in the region. Europe will be the second largest market. The Asia Pacific will grow at the fastest rate over the forecast period. Increasing healthcare expenditure and growing attention towards oncology nutrition are the driving factors for the growth of the oncology nutrition market in this region. Latin America market is projected to grow at a moderate rate during the forecast period. The Middle East and Africa are expected to experience noticeable growth in the years to come.

Some of the key players in oncology nutrition market include Fresenius Kabi AG, Nestle S.A., Abbott Laboratories, Danone, Global Health Products, Mead Johnson Nutrition Company, B.Braun Melsungen AG, Victus, Meiji Holdings, and Hormel Foods, among others.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com